AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMODIAQUINE + ARTESUNATE
19 registrations across 3 African markets— 18 active
Markets with AMODIAQUINE + ARTESUNATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| NONE TABLET; ORAL | 🇿🇼Zimbabwe | MICRO LABS LIMITED | active | Nov 2030 |
| NONE TABLET; ORAL | 🇿🇼Zimbabwe | MICRO LABS LIMITED | active | Nov 2030 |
| AMONATE COMBINATION PRODUCT TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2011 |
| AMONATE FDC comprimé / 100 mg / 400 mg | 🇸🇳Senegal | DAFRA | active | — |
| ARTESUNATE / AMODIAQUINE MEDIS comprimé / 100 mg / 270 mg | 🇸🇳Senegal | MEDIS | active | — |
| ARTESUNATE AMODIAQUINE WINTHROP comprimé / 100 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| ARTESUNATE / AMODIAQUINE MEDIS comprimé / 25 mg / 67.5 mg | 🇸🇳Senegal | MEDIS | active | — |
| ARTESUNATE+AMODIAQUINE SANOFI comprimé / 25 mg / 67,5 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| COARSUCAM comprimé / 10 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| ARTESUNATE+AMODIAQUINE SANOFI comprimé / 135 mg / 50 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| COARSUCAM comprimé / 135 mg / 50 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| ARTESUNATE+AMODIAQUINE SANOFI comprimé / 100 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| ARTESUNATE / AMODIAQUINE MEDIS comprimé / 135 mg / 50 mg | 🇸🇳Senegal | MEDIS | active | — |
| ARTESUNATE+AMODIAQUINE SANOFI comprimé / 100 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| AMONATE FDC comprimé / 100 mg / 400 mg | 🇸🇳Senegal | DAFRA | active | — |
| COARSUCAM comprimé / 100 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| COARSUCAM comprimé / 25 mg / 67,5 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| COARSUCAM comprimé / 100 mg / 270 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
| COARSUCAM comprimé / 25 mg / 67,5 mg | 🇸🇳Senegal | SANOFI AVENTIS MAROC | active | — |
AMODIAQUINE + ARTESUNATE in Africa — Regulatory Overview
AMODIAQUINE + ARTESUNATE is registered across 3 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Zimbabwe, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 19 registrations, 18 (95%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.